28 results on '"Gil Friedman"'
Search Results
2. BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
- Author
-
Lee Shaashua, Aviad Ben-Shmuel, Meirav Pevsner-Fischer, Gil Friedman, Oshrat Levi-Galibov, Subhiksha Nandakumar, Debra Barki, Reinat Nevo, Lauren E. Brown, Wenhan Zhang, Yaniv Stein, Chen Lior, Han Sang Kim, Linda Bojmar, William R. Jarnagin, Nicolas Lecomte, Shimrit Mayer, Roni Stok, Hend Bishara, Rawand Hamodi, Ephrat Levy-Lahad, Talia Golan, John A. Porco, Christine A. Iacobuzio-Donahue, Nikolaus Schultz, David A. Tuveson, David Lyden, David Kelsen, and Ruth Scherz-Shouval
- Subjects
Science - Abstract
Cancer-associated fibroblasts are transcriptionally rewired by signals from the cancer cells, resulting in heterogeneous populations. Here the authors show that loss of BRCA function in pancreatic cancer cells leads to HSF1–dependent accumulation of immune-regulatory clusterin-positive cancer associated fibroblasts.
- Published
- 2022
- Full Text
- View/download PDF
3. Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer
- Author
-
Oshrat Levi-Galibov, Hagar Lavon, Rina Wassermann-Dozorets, Meirav Pevsner-Fischer, Shimrit Mayer, Esther Wershof, Yaniv Stein, Lauren E. Brown, Wenhan Zhang, Gil Friedman, Reinat Nevo, Ofra Golani, Lior H. Katz, Rona Yaeger, Ido Laish, John A. Porco, Erik Sahai, Dror S. Shouval, David Kelsen, and Ruth Scherz-Shouval
- Subjects
Science - Abstract
Expression and activation of Heat shock factor 1 (HSF1) in cancer associated fibroblasts have been associated with protumorigenic functions. Here the authors show that, in a model of colitis-induced colorectal cancer, HSF1 is activated in stromal fibroblasts in the early stages of inflammation, leading to extracellular matrix remodelling that sustains tumor initiation and progression.
- Published
- 2020
- Full Text
- View/download PDF
4. Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice
- Author
-
Bo Hu, Gil Friedman, Eran Elinav, and Richard A Flavell
- Subjects
asc ,colon cancer ,inflammasome ,microflora ,nlrp6 ,Immunologic diseases. Allergy ,RC581-607 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
The microbiota is pivotal in orchestrating the pathogenesis of IBD-associated colorectal cancer (CRC). We recently demonstrated that altered elements in the microbiota of inflammasome-deficient mice drive transmissible inflammation-induced CRC. This microbiota-mediated effect is dependent upon microbiome-induced CCL5-driven inflammation, which, in turn, promotes epithelial cell proliferation through local activation of the IL-6 pathway, leading to cancer development.
- Published
- 2019
- Full Text
- View/download PDF
5. Enteropathogenic Escherichia coli remodels host endosomes to promote endocytic turnover and breakdown of surface polarity.
- Author
-
Ephrem G Kassa, Efrat Zlotkin-Rivkin, Gil Friedman, Rachana P Ramachandran, Naomi Melamed-Book, Aryeh M Weiss, Michael Belenky, Dana Reichmann, William Breuer, Ritesh Ranjan Pal, Ilan Rosenshine, Lynne A Lapierre, James R Goldenring, and Benjamin Aroeti
- Subjects
Immunologic diseases. Allergy ,RC581-607 ,Biology (General) ,QH301-705.5 - Abstract
Enteropathogenic E. coli (EPEC) is an extracellular diarrheagenic human pathogen which infects the apical plasma membrane of the small intestinal enterocytes. EPEC utilizes a type III secretion system to translocate bacterial effector proteins into its epithelial hosts. This activity, which subverts numerous signaling and membrane trafficking pathways in the infected cells, is thought to contribute to pathogen virulence. The molecular and cellular mechanisms underlying these events are not well understood. We investigated the mode by which EPEC effectors hijack endosomes to modulate endocytosis, recycling and transcytosis in epithelial host cells. To this end, we developed a flow cytometry-based assay and imaging techniques to track endosomal dynamics and membrane cargo trafficking in the infected cells. We show that type-III secreted components prompt the recruitment of clathrin (clathrin and AP2), early (Rab5a and EEA1) and recycling (Rab4a, Rab11a, Rab11b, FIP2, Myo5b) endocytic machineries to peripheral plasma membrane infection sites. Protein cargoes, e.g. transferrin receptors, β1 integrins and aquaporins, which exploit the endocytic pathways mediated by these machineries, were also found to be recruited to these sites. Moreover, the endosomes and cargo recruitment to infection sites correlated with an increase in cargo endocytic turnover (i.e. endocytosis and recycling) and transcytosis to the infected plasma membrane. The hijacking of endosomes and associated endocytic activities depended on the translocated EspF and Map effectors in non-polarized epithelial cells, and mostly on EspF in polarized epithelial cells. These data suggest a model whereby EPEC effectors hijack endosomal recycling mechanisms to mislocalize and concentrate host plasma membrane proteins in endosomes and in the apically infected plasma membrane. We hypothesize that these activities contribute to bacterial colonization and virulence.
- Published
- 2019
- Full Text
- View/download PDF
6. Supplementary Table 6 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
Patient data and univariate analysis of gastric cancer patient cohorts
- Published
- 2023
7. Supplementary Table 8 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
RNA-seq data of PDPN+ cancer-associated fibroblasts (CAFs) from triple-transgenic gastric cancer mice
- Published
- 2023
8. Supplementary Table 3 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
RNA-seq results of stroma and cancer from gastric cancer patients
- Published
- 2023
9. Supplementary Table 7 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
Gene set enrichment analysis (GSEA) using MSigDB (Hallmark gene sets) on the full stromal patient RNA-seq data
- Published
- 2023
10. Supplementary Table 2 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
Distances of patient samples in PCA analysis
- Published
- 2023
11. Supplementary Table 4 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
Pathway analysis of stroma from gastric cancer patients
- Published
- 2023
12. Supplementary Table 1 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
Clinical characteristics of the gastric cancer patient cohort
- Published
- 2023
13. Supplementary Materials&Methods and Supplementary Figures 1-6 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
This file contains Supplementary Materials and Methods, Supplementary Figure Legends, and 6 Supplementary Figures with their legends
- Published
- 2023
14. Supplementary Table 5 from Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles
- Author
-
Ruth Scherz-Shouval, Irit Ben-Aharon, Neta Regev-Rudzki, David Lyden, Andrzej A. Dlugosz, Baruch Brenner, Salomon M. Stemmer, Eyal Shimoni, Cristina Migliore, Li-Jyun Syu, Yifat Ofir-Birin, Gil Friedman, Oshrat Levi-Galibov, Shimrit Mayer, Hagar Lavon, Yaniv Stein, Judith Diment, Tal Goshen-Lago, Meirav Pevsner-Fischer, and Nil Grunberg
- Abstract
Summary of Kaplan-Meier curves from the TCGA cohort
- Published
- 2023
15. Reproductive outcome after early pregnancy loss treated with misoprostol versus surgical aspiration
- Author
-
Ilia Kleiner, Ariel Weissman, Gil Friedman, Jacob Bar, Yossi Mizrachi, Ram Kerner, Arieh Raziel, Emilie Ben-Ezry, and Ron Sagiv
- Subjects
Adult ,0301 basic medicine ,medicine.medical_specialty ,Early Pregnancy Loss ,Abortion ,Miscarriage ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,medicine ,Humans ,Paracentesis ,Misoprostol ,Abortifacient Agents, Nonsteroidal ,030219 obstetrics & reproductive medicine ,Obstetrics ,business.industry ,Reproduction ,Pregnancy Outcome ,Obstetrics and Gynecology ,Gestational age ,medicine.disease ,Abortion, Spontaneous ,Pregnancy Trimester, First ,Pregnancy rate ,Treatment Outcome ,030104 developmental biology ,Reproductive Medicine ,Female ,Live birth ,business ,Developmental Biology ,medicine.drug ,Cohort study - Abstract
Research question Does long-term reproductive outcome after early pregnancy loss (EPL) differ between women who are treated with misoprostol and surgical aspiration. Design A historic cohort study of all women who were diagnosed with early pregnancy loss (≤12 weeks), in a single medical centre, between September 2016 and August 2017, was conducted. The women were treated with either misoprostol or surgical aspiration according to their own preferences. Women who were lost to follow-up or did not attempt to conceive again were excluded. The primary outcome measure was the cumulative pregnancy rate within 12 months from intervention. Results Baseline characteristics were comparable between women who received misoprostol (n = 163) and women who underwent surgical aspiration (n = 122). Women who received misoprostol had a higher rate of interventions for retained products of conception (11.0% versus 3.3%, respectively; P = 0.015). The misoprostol and the surgical aspiration groups did not differ in rate of repeated miscarriages (17.8% versus 21.3%, respectively; P = 0.45), or pregnancy rate within 6 months (58.3% versus 50.0%, respectively; P = 0.16), 12 months (78.5% versus 78.7%, respectively; P = 0.97) and 24 months (92.0% versus 91.8%, respectively; P = 0.94). Live birth rate within 24 months was comparable (62.0% versus 58.2%, respectively; P = 0.52), as well as gestational age at birth (38.5 versus 38.6 weeks, respectively; P = 0.81) and birthweight (3295 versus 3161 g, respectively; P = 0.07). Conclusions Long-term reproductive outcomes are comparable in women with EPL who are treated with either misoprostol or surgical aspiration. Our findings may help counselling patients facing EPL who have concerns about their future reproduction.
- Published
- 2020
16. Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
- Author
-
Coral Halperin, Ruth Scherz-Shouval, Oshrat Levi-Galibov, Shimrit Mayer, Carlos Caldas, Avi Mayo, Einav Nili-Gal-Yam, Reinat Nevo, Yaniv Stein, Amir Giladi, Chamutal Bornstein, Eyal David, Nora Balint-Lahat, Ido Amit, Hagar Lavon, Maya Dadiani, Gil Friedman, H. Raza Ali, Iris Barshack, Meirav Pevsner-Fischer, and Uri Alon
- Subjects
Change over time ,Cancer Research ,Disease outcome ,business.industry ,Cancer associated fibroblast ,medicine.disease ,Breast tumor ,Cancer treatment ,medicine.anatomical_structure ,Breast cancer ,Oncology ,medicine ,Cancer research ,skin and connective tissue diseases ,Fibroblast ,business ,PDPN - Abstract
Tumors are supported by cancer-associated fibroblasts (CAFs). CAFs are heterogeneous and carry out distinct cancer-associated functions. Understanding the full repertoire of CAFs and their dynamic changes as tumors evolve could improve the precision of cancer treatment. Here we comprehensively analyze CAFs using index and transcriptional single-cell sorting at several time points along breast tumor progression in mice, uncovering distinct subpopulations. Notably, the transcriptional programs of these subpopulations change over time and in metastases, transitioning from an immunoregulatory program to wound-healing and antigen-presentation programs, indicating that CAFs and their functions are dynamic. Two main CAF subpopulations are also found in human breast tumors, where their ratio is associated with disease outcome across subtypes and is particularly correlated with BRCA mutations in triple-negative breast cancer. These findings indicate that the repertoire of CAF changes over time in breast cancer progression, with direct clinical implications. Scherz-Shouval and colleagues characterize the dynamic changes in cancer-associated fibroblast subpopulations during breast cancer progression. They find that the ratio of S100A4+ and PDPN+ CAF subsets is associated with clinical outcome.
- Published
- 2020
17. BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking CLU+ CAF expression with HSF1 signaling
- Author
-
John A. Porco, Subhiksha Nandakumar, Nicolas Lecomte, Talia Golan, Lee Shaashua, Ruth Scherz-Shouval, David A. Tuveson, Ephrat Levy-Lahad, Nikolaus Schultz, Roni Stok, Christine A. Iacobuzio-Donahue, David P. Kelsen, Rawand Hamodi, Yaniv Stein, Meirav Pevsner-Fischer, Han Sang Kim, Reinat Nevo, Wenhan Zhang, Oshrat Levi-Galibov, Lauren E. Brown, Hend Bishara, David Lyden, Gil Friedman, Linda Bojmar, and William R. Jarnagin
- Subjects
Tumor microenvironment ,Stromal cell ,Clusterin ,Tumor progression ,Pancreatic cancer ,Cancer cell ,medicine ,Cancer research ,biology.protein ,Cancer ,Biology ,medicine.disease ,Metastasis - Abstract
Cancer-associated fibroblasts (CAFs) give rise to desmoplastic stroma, which supports tumor progression and metastasis, and comprises up to 90% of the tumor mass in pancreatic cancer. Recent work by us and others has shown that CAFs are transcriptionally rewired by adjacent cancer cells to form heterogeneous subtypes. Whether this rewiring is differentially affected by different driver mutations in cancer cells is largely unknown. Here we address this question by dissecting and comparing the stromal landscape of BRCA-mutated and BRCA Wild-type (WT) pancreatic ductal adenocarcinoma (PDAC). We comprehensively analyze PDAC samples from a cohort of 42 patients by laser-capture microdissection, RNA-sequencing and multiplexed immunofluorescence, revealing different CAF subtype compositions in germline BRCA-mutated vs. BRCA-WT tumors. In particular, we detect an increase in a subset of Clusterin (CLU)-positive CAFs in BRCA-mutated tumors. We further unravel a network of stress responses upregulated in BRCA-mutated tumors. Using cancer organoids and cell co-cultures, we show that the transcriptional shift of pancreatic stellate cells into CLU+ CAFs is mediated through activation of heat-shock factor 1 (HSF1), the transcriptional regulator of Clu. Our findings unravel a new dimension of stromal heterogeneity, influenced by germline mutations in cancer cells, with direct translational implications for clinical research.SignificanceBRCA1/2 mutations initiate some of the deadliest cancers, yet the fibroblastic microenvironment of BRCA-mutated cancers remains uncharted. Our work addresses a major unsolved question – to what extent is the tumor microenvironment determined by cancer mutations? We find that BRCA mutations in the cancer cells affect the composition of CAFs in PDAC. These findings have direct implications for diagnosis and for efforts to exploit CAFs for therapy.
- Published
- 2021
18. Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer
- Author
-
John A. Porco, Shimrit Mayer, Yaniv Stein, Esther Wershof, Dror S. Shouval, Erik Sahai, Ido Laish, Meirav Pevsner-Fischer, Lauren E. Brown, David P. Kelsen, Wenhan Zhang, Oshrat Levi-Galibov, Reinat Nevo, Hagar Lavon, Ruth Scherz-Shouval, Lior H. Katz, Gil Friedman, Rina Wassermann-Dozorets, Rona Yaeger, and Ofra Golani
- Subjects
Cancer microenvironment ,Proteomics ,0301 basic medicine ,Mice, 129 Strain ,Stromal cell ,Proteome ,Colorectal cancer ,Science ,General Physics and Astronomy ,Inflammation ,Tumor initiation ,Article ,Mass Spectrometry ,General Biochemistry, Genetics and Molecular Biology ,Extracellular matrix ,03 medical and health sciences ,0302 clinical medicine ,Heat Shock Transcription Factors ,Cell Line, Tumor ,Animals ,Humans ,Medicine ,HSF1 ,Cells, Cultured ,Mice, Knockout ,Mice, Inbred BALB C ,Multidisciplinary ,business.industry ,fungi ,General Chemistry ,medicine.disease ,Colon cancer ,Extracellular Matrix ,3. Good health ,Heat shock factor ,Disease Models, Animal ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cancer research ,Cancer-Associated Fibroblasts ,Colitis-Associated Neoplasms ,medicine.symptom ,business - Abstract
In the colon, long-term exposure to chronic inflammation drives colitis-associated colon cancer (CAC) in patients with inflammatory bowel disease. While the causal and clinical links are well established, molecular understanding of how chronic inflammation leads to the development of colon cancer is lacking. Here we deconstruct the evolving microenvironment of CAC by measuring proteomic changes and extracellular matrix (ECM) organization over time in a mouse model of CAC. We detect early changes in ECM structure and composition, and report a crucial role for the transcriptional regulator heat shock factor 1 (HSF1) in orchestrating these events. Loss of HSF1 abrogates ECM assembly by colon fibroblasts in cell-culture, prevents inflammation-induced ECM remodeling in mice and inhibits progression to CAC. Establishing relevance to human disease, we find high activation of stromal HSF1 in CAC patients, and detect the HSF1-dependent proteomic ECM signature in human colorectal cancer. Thus, HSF1-dependent ECM remodeling plays a crucial role in mediating inflammation-driven colon cancer., Expression and activation of Heat shock factor 1 (HSF1) in cancer associated fibroblasts have been associated with protumorigenic functions. Here the authors show that, in a model of colitis-induced colorectal cancer, HSF1 is activated in stromal fibroblasts in the early stages of inflammation, leading to extracellular matrix remodelling that sustains tumor initiation and progression.
- Published
- 2020
19. Cancer-associated fibroblast compositions change with breast-cancer progression linking S100A4 and PDPN ratios with clinical outcome
- Author
-
Maya Dadiani, Nili-Gal-Yam E, Yaniv Stein, Ruth Scherz-Shouval, Eyal David, Ido Amit, Reinat Nevo, Amir Giladi, Avraham E. Mayo, Gil Friedman, Ali Hr, Oshrat Levi-Galibov, Uri Alon, Meirav Pevsner-Fischer, Coral Halperin, Carlos Caldas, Chamutal Bornstein, and Hagar Lavon
- Subjects
Change over time ,business.industry ,Disease outcome ,Cancer associated fibroblast ,medicine.disease ,Cancer treatment ,Breast tumor ,Breast cancer ,Cancer research ,Medicine ,skin and connective tissue diseases ,business ,PDPN ,Human breast - Abstract
Tumors are supported by cancer-associated fibroblasts (CAFs). CAFs are heterogeneous and carry out distinct cancer-associated functions. Understanding the full repertoire of CAFs and their dynamic changes could improve the precision of cancer treatment. CAFs are usually analyzed at a single time-point using specific markers, and it is therefore unclear whether CAFs display plasticity as tumors evolve. Here, we analyze thousands of CAFs using index and transcriptional single-cell sorting, at several time-points along breast tumor progression in mice, uncovering distinct subpopulations. Strikingly, the transcriptional programs of these subpopulations change over time and in metastases, transitioning from an immune-regulatory program to wound healing and antigen-presentation programs, indicating that CAFs and their functions are dynamic. Two main CAF subpopulations are also found in human breast tumors, where their ratio is associated with disease outcome across subtypes, and is particularly correlated with BRCA mutations in triple-negative breast cancer. These findings indicate that the repertoire of CAFs changes over time in breast cancer progression, with direct clinical implications.
- Published
- 2020
20. Abstract LB204: HSF1 promotes inflammation induced tumor development through ECM remodeling
- Author
-
David P. Kelsen, Dror S. Shouval, Oshrat Levi Galibov, Ruth Scherz-Shouval, John A. Porco, Lior H. Katz, Shimrit Mayer, Hagar Lavon, Erik Sahai, Meirav Pevsner-Fischer, Rona Yaeger, Reinat Nevo, Ido Laish, Rina Wassermann-Dozorets, Wenhan Zhang, Lauren E. Brown, Ofra Golani, Gil Friedman, Yaniv Stein, and Esther Wershof
- Subjects
Cancer Research ,Tumor microenvironment ,Stromal cell ,Cancer ,Tumor initiation ,Biology ,medicine.disease ,Metastasis ,Extracellular matrix ,Oncology ,Cancer cell ,medicine ,Cancer research ,Reprogramming - Abstract
HSF1 promotes inflammation induced tumor development through ECM remodelingAbstractIn the colon, long-term exposure to chronic inflammation drives colitis associated colon cancer (CAC) in patients with inflammatory bowel disease (IBD). Chronic inflammation underlies tumor initiation, promotion, invasion, and metastasis. While the causal and clinical link between chronic inflammation and CAC is well established, we lack a molecular understanding of what is the way in which chronic inflammation leads to develop colon cancer. Within the tumor, cancer cells are surrounded by a variety of non-malignant cells, such as macrophages, endothelial cells, neutrophils, cancer-associated fibroblasts (CAFs), and together with the extracellular matrix (ECM) they compose the tumor microenvironment (TME), also termed the stroma. Even the most aggressive cancers depend and interact with their environment mostly through secreted factors. Unlike cancer cells, stromal cells are genomically stable, and do not harbor oncogenic mutations that could drive their co-evolution and functional reprogramming. Rather, stromal reprogramming is thought to be achieved by transcriptional rewiring. Previous work by us and others has shown that the master regulator heat shock factor 1 (HSF1) plays a crucial role in this process, by mediating a transcriptional program in fibroblasts that enables their reprogramming into cancer-associated fibroblasts (CAFs) to promote malignancy. We hypothesizde that HSF1 plays a crucial role in inflammation-driven cancer by initiation of a transcriptional program that leads to changes in the extracellular matrix (ECM). We found that, in cell culture, cancer-induced ECM assembly by fibroblasts requires HSF1. Using an inflammation-driven cancer model in mice, we measured the changes in proteomic and ECM organization over time. We found that HSF1 drives a transcriptional program that leads to ECM remodeling in early stages and results in development of colon cancer. Loss of HSF1 prevents inflammation-induced ECM remodeling. Further to that, in CAC patients, we found high activation of stromal HSF1 and similarity to our HSF1 proteomic ECM signature in human colorectal cancer driven by HSF1. Thus, HSF1-dependent ECM remodeling mediates the transition from chronic inflammation to colon cancer. Citation Format: Oshrat Levi Galibov, Hagar Lavon, Rina Wassermann-Dozorets, Meirav Pevsner-Fischer, Shimrit Mayer, Esther Wershof, Yaniv Stein, Lauren E. Brown, Wenhan Zhang, Gil Friedman, Reinat Nevo, Ofra Golani, Lior H. Katz, Rona Yaeger, Ido Laish, John A. Porco, Erik Sahai, Dror S Shouval, David Kelsen, Ruth Scherz-Shouval. HSF1 promotes inflammation induced tumor development through ECM remodeling [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr LB204.
- Published
- 2021
21. Abstract LB009: Dynamic changes in the compositions of cancer associated-fibroblasts correlate with clinical outcome in breast cancer
- Author
-
Ido Amit, Ruth Scherz-Shouval, Reinat Nevo, Eyal David, Avi Mayo, Yaniv Stein, Maya Dadiani, Gil Friedman, Oshrat Levi-Galibov, Coral Halperin, Uri Alon, H. Raza Ali, Meirav Pevsner-Fischer, Iris Barshack, Amir Giladi, Hagar Lavon, Shimrit Mayer, Einav Nili Gal-Yam, Carlos Caldas, Chamutal Bornstein, and Nora Balint-Lahat
- Subjects
Oncology ,Change over time ,Cancer Research ,medicine.medical_specialty ,Disease outcome ,business.industry ,Cancer ,medicine.disease ,Breast tumor ,Cancer treatment ,Breast cancer ,Internal medicine ,medicine ,Cancer-Associated Fibroblasts ,business ,Human breast - Abstract
Cancer associated fibroblasts (CAFs) are prevalent in carcinomas. CAFs are also heterogeneous and perform various tumor-promoting tasks. Understanding whether distinct CAF-subsets exert specific functions, and how the composition of CAFs changes as tumors evolve could improve the accuracy of cancer treatment. Here, we analyzed thousands of CAFs by single-cell RNA-sequencing and index-sorting at several timepoints along breast tumor progression in mice, revealing distinct CAF-subsets. We discovered that the transcriptional programs of these subsets change over time, shifting from an immune-regulatory program at earlier timepoints to wound-healing and antigen-presenting programs at later timepoints, indicating that the composition and functions of CAFs are dynamic. We also found the two main CAF subsets in human breast tumors, wherein their ratio was associated with disease outcome. This association was particularly correlated with BRCA mutations in triple-negative breast cancer. Our findings indicate that the diverse composition of CAFs in breast cancer changes over time as tumors progress, and that these changes are linked to disease outcome. Citation Format: Gil Friedman, Oshrat Levi-Galibov, Eyal David, Chamutal Bornstein, Amir Giladi, Maya Dadiani, Avi Mayo, Coral Halperin, Meirav Pevsner-Fischer, Hagar Lavon, Shimrit Mayer, Reinat Nevo, Yaniv Stein, Nora Balint-Lahat, Iris Barshack, H. Raza Ali, Carlos Caldas, Einav Nili Gal-Yam, Uri Alon, Ido Amit, Ruth Scherz-Shouval. Dynamic changes in the compositions of cancer associated-fibroblasts correlate with clinical outcome in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr LB009.
- Published
- 2021
22. Transmissible inflammation-induced colorectal cancer in inflammasome-deficient mice
- Author
-
Richard A. Flavell, Gil Friedman, Eran Elinav, and Bo Hu
- Subjects
0301 basic medicine ,lcsh:Immunologic diseases. Allergy ,Colorectal cancer ,Immunology ,Inflammation ,digestive system ,lcsh:RC254-282 ,Pathogenesis ,03 medical and health sciences ,0302 clinical medicine ,inflammasome ,medicine ,Deficient mouse ,Immunology and Allergy ,Author's View ,NLRP6 ,business.industry ,Inflammasome ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,asc ,Epithelium ,digestive system diseases ,stomatognathic diseases ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,colon cancer ,030220 oncology & carcinogenesis ,Cancer research ,Cancer development ,microflora ,medicine.symptom ,business ,lcsh:RC581-607 ,nlrp6 ,medicine.drug - Abstract
The microbiota is pivotal in orchestrating the pathogenesis of IBD-associated colorectal cancer (CRC). We recently demonstrated that altered elements in the microbiota of inflammasome-deficient mice drive transmissible inflammation-induced CRC. This microbiota-mediated effect is dependent upon microbiome-induced CCL5-driven inflammation, which, in turn, promotes epithelial cell proliferation through local activation of the IL-6 pathway, leading to cancer development.
- Published
- 2019
23. Enteropathogenic Escherichia coli remodels host endosomes to promote endocytic turnover and breakdown of surface polarity
- Author
-
Rachana Pattani Ramachandran, Michael Belenky, William Breuer, Naomi Melamed-Book, Lynne A. Lapierre, Benjamin Aroeti, Ritesh Ranjan Pal, Ilan Rosenshine, Efrat Zlotkin-Rivkin, Gil Friedman, Ephrem G. Kassa, James R. Goldenring, Aryeh Weiss, and Dana Reichmann
- Subjects
Confocal Microscopy ,Cell Membranes ,Endocytic cycle ,Cultured tumor cells ,Diagnostic Radiology ,Enteropathogenic Escherichia coli ,Spectrum Analysis Techniques ,Medicine and Health Sciences ,Biology (General) ,Escherichia coli Infections ,Microscopy ,0303 health sciences ,Secretory Pathway ,biology ,Chemistry ,Radiology and Imaging ,030302 biochemistry & molecular biology ,Infection Imaging ,Light Microscopy ,Flow Cytometry ,Endocytosis ,Cell biology ,Transcytosis ,Cell Processes ,Spectrophotometry ,Cell lines ,Cytophotometry ,Cellular Structures and Organelles ,Biological cultures ,Research Article ,Imaging Techniques ,Endosome ,QH301-705.5 ,Immunology ,Endosomes ,Microbiology ,Clathrin ,EEA1 ,03 medical and health sciences ,Diagnostic Medicine ,Virology ,Genetics ,Humans ,Secretion ,Vesicles ,HeLa cells ,Molecular Biology ,030304 developmental biology ,Cell Membrane ,Biology and Life Sciences ,Membrane Proteins ,Cell Biology ,RC581-607 ,Cell cultures ,Research and analysis methods ,Membrane protein ,biology.protein ,Parasitology ,Immunologic diseases. Allergy - Abstract
Enteropathogenic E. coli (EPEC) is an extracellular diarrheagenic human pathogen which infects the apical plasma membrane of the small intestinal enterocytes. EPEC utilizes a type III secretion system to translocate bacterial effector proteins into its epithelial hosts. This activity, which subverts numerous signaling and membrane trafficking pathways in the infected cells, is thought to contribute to pathogen virulence. The molecular and cellular mechanisms underlying these events are not well understood. We investigated the mode by which EPEC effectors hijack endosomes to modulate endocytosis, recycling and transcytosis in epithelial host cells. To this end, we developed a flow cytometry-based assay and imaging techniques to track endosomal dynamics and membrane cargo trafficking in the infected cells. We show that type-III secreted components prompt the recruitment of clathrin (clathrin and AP2), early (Rab5a and EEA1) and recycling (Rab4a, Rab11a, Rab11b, FIP2, Myo5b) endocytic machineries to peripheral plasma membrane infection sites. Protein cargoes, e.g. transferrin receptors, β1 integrins and aquaporins, which exploit the endocytic pathways mediated by these machineries, were also found to be recruited to these sites. Moreover, the endosomes and cargo recruitment to infection sites correlated with an increase in cargo endocytic turnover (i.e. endocytosis and recycling) and transcytosis to the infected plasma membrane. The hijacking of endosomes and associated endocytic activities depended on the translocated EspF and Map effectors in non-polarized epithelial cells, and mostly on EspF in polarized epithelial cells. These data suggest a model whereby EPEC effectors hijack endosomal recycling mechanisms to mislocalize and concentrate host plasma membrane proteins in endosomes and in the apically infected plasma membrane. We hypothesize that these activities contribute to bacterial colonization and virulence., Author summary Enteropathogenic Escherichia coli (EPEC) are pathogenic bacteria that cause infantile diarrhea. Upon ingestion, EPEC reaches the small intestine, where an injection device termed the type III secretion system is utilized to inject a set of effector proteins from the bacteria into the host cell. These proteins manipulate the localization and functions of host proteins, lipids and organelles and contribute to the emergence of the EPEC disease. The molecular mechanisms underlying the functions of the EPEC effector proteins are not completely understood. Here we show that early upon infection, two such effector proteins, EspF and Map, hijack host endosomes at bacterial adherence sites to facilitate endocytosis and recycling of plasma membrane proteins at these sites. The consequence of this event is the enrichment and mislocalization of host plasma membrane proteins at infection sites. One such protein is the transferrin receptor, which is a carrier for transferrin, whose function is to mediate cellular uptake of iron. Iron is a critical nutrient for bacterial growth and survival. We postulate that the unique manipulation of transferrin receptor endocytic membrane trafficking by EPEC plays an important role in its survival on the luminal surface of the intestinal epithelium.
- Published
- 2019
24. Strategic deficiencies in national liberation struggles: The case of fatah in the al-Aqsa Intifada
- Author
-
Gil Friedman
- Subjects
Sociology and Political Science ,Aggression ,Green line ,Refugee ,Opposition (politics) ,Indignation ,Politics ,Political science ,Law ,Political economy ,Political Science and International Relations ,medicine ,Asymmetric warfare ,medicine.symptom ,West bank - Abstract
This study reports and explains a cluster of deviations from the basic rational criteria of national liberation strategy exhibited by ‘inside’ West Bank Fatah leaders during the al-Aqsa uprising, based on an analysis of public statements of three such leaders. The leaders fail to recognize that their attempt to deter Israeli offensives by threatening to reciprocate them with attacks inside the Green Line is sabotaged by Islamists independently attacking inside the Green Line; inadequately attend to the distinct possibility that attacks within the Green Line increase Israeli opposition to desired concessions on refugees and territory; and appear to occasionally get swept-up in the sentiment that reciprocating Israeli aggression is inherently just. The study elaborates and examines the possible roles in these strategic deficiencies of leader strategic desperation; rage and indignation; and the political need to satisfy widespread popular militancy. The study's logic complements existing asymmetric ...
- Published
- 2008
25. Commercial Pacifism and Protracted Conflict
- Author
-
Gil Friedman
- Subjects
Economic integration ,medicine.medical_specialty ,Sociology and Political Science ,media_common.quotation_subject ,0211 other engineering and technologies ,02 engineering and technology ,Public opinion ,Development economics ,050602 political science & public administration ,medicine ,Economics ,Economic impact analysis ,Diplomacy ,Economic consequences ,media_common ,021110 strategic, defence & security studies ,business.industry ,Conflict economics ,05 social sciences ,General Business, Management and Accounting ,Economic exchange ,0506 political science ,Incentive ,Political economy ,Political Science and International Relations ,business - Abstract
This study examines commercial pacifism and protracted conflict. It identifies constraints posed by protracted conflict on both the opportunity of the rivals to engage in mutually beneficial economic exchange and the impact of economic incentives on views on violence and peace. Based on this discussion, the study estimates regression models of Palestinians'views on diplomacy and attacks with 2001 public opinion data. The models suggest a modest role for economics. Views on Palestinian-Israeli economic integration and the economic impact of future peace exert important effects on views on diplomacy; income level and views on the economic consequences of Palestinian rebellion do not. Realist concerns appear to play the dominant role in views on attacks. Split-sample models reveal important interaction effects: the effects of economic incentives are substantively stronger and realist considerations sometimes weaker among people who deem economics the most important issue. All estimated models leave most of the variance unexplained.
- Published
- 2005
26. Retraction of enteropathogenic E. coli type IV pili promotes efficient host cell colonization, effector translocation and tight junction disruption
- Author
-
Gil Friedman, Michael S. Donnenberg, Benjamin Aroeti, and Efrat Zlotkin-Rivkin
- Subjects
Microbiology (medical) ,Virulence Factors ,Virulence ,Chromosomal translocation ,macromolecular substances ,Biology ,medicine.disease_cause ,Microbiology ,Pilus ,Bacterial Adhesion ,Cell Line ,Tight Junctions ,Enteropathogenic Escherichia coli ,medicine ,Animals ,Humans ,Microscopy ,Tight junction ,Effector ,Escherichia coli Proteins ,digestive, oral, and skin physiology ,Gastroenterology ,food and beverages ,Pathogenic bacteria ,Epithelial Cells ,Transport protein ,Cell biology ,Article Addendum ,Protein Transport ,Infectious Diseases ,Fimbriae, Bacterial - Abstract
Type IV pili (Tfp) play a primary role in mediating the adherence of pathogenic bacteria to their hosts. The pilus filament can retract with an immense force. However, the role of this activity in microbial pathogenesis has not been rigorously explored. Experiments performed on volunteers suggested that the retraction capacity of enteropathogenic Escherichia coli (EPEC) Tfp is required for full virulence. Here we review our recent study(1) in which we showed that the retraction capacity of the EPEC Tfp facilitates tight-junction disruption and actin-rich pedestal formation by promoting efficient bacterial protein effector translocation into epithelial host cells. We also present new data using live imaging confocal microscopy suggesting that EPEC adheres to monolayers in microcolonies and that Tfp retraction facilitates significant changes in the microcolony shape, which may be critical for efficient effector delivery. Our studies hence suggest novel insights into the role of pili retraction in EPEC pathogenesis.
- Published
- 2012
27. Agency, Structure and International Politics
- Author
-
Gil Friedman and Harvey Starr
- Published
- 2002
28. Agency, Structure and International Politics : From Ontology to Empirical Inquiry
- Author
-
Gil Friedman, Harvey Starr, Gil Friedman, and Harvey Starr
- Subjects
- International relations--Philosophy, International relations--Methodology, International relations--Social aspects, Agent (Philosophy), Structuralism
- Abstract
The concepts of agency and structure are of increasing and defining importance to international relations and politics as fields of enquiry and knowledge. This is the first book to explore the two concepts in depth in that context.The agent-structure problem refers to questions concerning the interrelationship of agency and structure, and to the ways in which explanations of social phenomena integrate and account for them. This is an important contribution to the study of international relations and politics.
- Published
- 1997
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.